COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

…, MV Madhavan, D Jimenez, T Chuich, I Dreyfus… - Journal of the American …, 2020 - jacc.org
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …

[HTML][HTML] Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research

…, T Chuich, SN Nouri, I Dreyfus… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected …

Changes in atrial fibrillation admissions following daylight saving time transitions

JJ Chudow, I Dreyfus, L Zaremski, AY Mazori… - Sleep Medicine, 2020 - Elsevier
Background Daylight saving time (DST) imposes a twice-yearly hour shift. The transitions to
and from DST are associated with decreases in sleep quality and environmental hazards. …

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review

…, M Aghakouchakzadeh, I Dreyfus… - Journal of the American …, 2021 - jacc.org
Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation, endothelial
activation, and multiorgan manifestations. Lipid-modulating agents may be useful in …

Lipid-modulating agents for prevention or treatment of COVID-19 in randomized trials

…, P Sadeghipour, M Aghakouchakzadeh, I Dreyfus… - medRxiv, 2021 - medrxiv.org
Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation, endothelial
activation, and multi-organ manifestations. Lipid modulating agents may be useful in …

TCT-616 IVUS as an Adjunct to Digital Subtraction Angiography in the Treatment of Peripheral Arterial Disease

D Saleem, I Dreyfus, D Snyder, R Zilinyi, S Min… - Journal of the American …, 2023 - jacc.org
Background Intravascular ultrasound (IVUS) use has been shown to reduce rates of restenosis
in femoropopliteal peripheral arterial disease (PAD) interventions when compared with …

Therapy for Renal Artery Stenosis: A Call for Change

I Dreyfus, R Zilinyin… - Journal of …, 2022 - journals.sagepub.com
Atherosclerosis is the most common cause of renal artery stenosis (RAS) and exerts its
effects through activation of the renin-angiotensin-aldosterone system (RAAS). Clinical …

OUTCOMES OF CONTEMPORARY NON-INFERIORITY VERSUS SUPERIORITY CARDIOVASCULAR TRIALS

I Dreyfus, N Varunok, M Madhavan, J Burton… - Journal of the American …, 2021 - jacc.org
Background Non-inferiority (NI) randomized controlled trials (RCTs) are increasingly used
to evaluate cardiovascular (CV) therapies. We determined the proportion of NI versus …

TCT-220 Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infra-Popliteal Endovascular Intervention

D Snyder, R Zilinyi, D Saleem, I Dreyfus, Z Girvin… - Journal of the American …, 2022 - jacc.org
Background Intravascular ultrasound (IVUS) use has been associated with lower rates of
binary restenosis when used in femoropopliteal artery interventions. The goal of this study was …

IDIOPATHIC PACEMAKER LEAD MIGRATION AS A CAUSE OF ARRHYTHMIA AND SEVERE PULMONIC VALVE DYSFUNCTION

I Dreyfus, A Stein-Merlob, AL Warner, JK Han… - Journal of the American …, 2024 - jacc.org
Background Idiopathic lead migration is a rare complication of pacemaker (PM) insertion.
We describe a case of lead migration with pulmonic valve (PV) compromise.